News

Interview with Dr. Anneke Hesseling – Part Three

This is part three of our interview with Dr. Hesseling. Click here to view part one. Click here to view part two.

Dr. Anneke Hesseling is the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa. She has South African and US training in Medicine and Epidemiology and is the PI and co-PI on several large research projects relates to the epidemiology, transmission and diagnosis of tuberculosis in children, with special emphasis on the interaction between pediatric TB and HIV and the immunologic diagnosis of TB infection and disease. Dr. Hesseling has a special research interest in the epidemiologic and immunologic interaction between BCG and HIV in children and is the chairperson of the IUATLD BCG Working Group.

An interview with Dr. Hesseling from the 41st Union World Conference on Lung Health in Berlin can be found on the Science Speaks blog here.

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...